Prelude Capital Management’s Teladoc Health TDOC Stock Holding History

Prelude Capital Management’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-6,000	Closed	-$1.15M	–	2333
2020 Q2	$1.15M	Sell	6,000 -2,300	-28%	-$403K	0.06%	280
2020 Q1	$1.29M	Buy	8,300 +5,600	+207%	+$652K	0.09%	167
2019 Q4	$226K	Sell	2,700 -400	-13%	-$30.4K	0.01%	817
2019 Q3	$210K	Buy	+3,100	New	+$204K	0.01%	754
2019 Q1	–	Sell	-1,000	Closed	-$50K	–	2167
2018 Q4	$50K	Buy	1,000 +900	+900%	+$55.1K	﹤0.01%	1111
2018 Q3	$9K	Buy	+100	New	+$7.13K	﹤0.01%	1486

Other funds holding TDOC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Prelude Capital Management's TDOC Position: Q1 2026 in Review

Prelude Capital Management increased its Teladoc Health (TDOC) stake by 4.1% in Q1 2026, buying an estimated $13.9K and bringing the position to 63,085 shares worth $344K. The position accounts for 0.03% of the portfolio, ranked #653.

Prelude Capital Management first reported a position in TDOC in Q1 2020 and has held it in 14 quarters since. The position peaked at $1.31M in Q3 2025. 323 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

Prelude Capital Management held 63,085 shares of Teladoc Health worth $344K as of Q1 2026.
Prelude Capital Management bought 2,485 Teladoc Health shares in Q1 2026, an estimated $13.9K.
Teladoc Health made up 0.03% of Prelude Capital Management's portfolio in Q1 2026, its #653 holding.
Prelude Capital Management first reported a position in Teladoc Health in Q1 2020 and has held it in 14 quarters since.
Prelude Capital Management's Teladoc Health position peaked at $1.31M in Q3 2025.
323 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.